{
    "clinical_study": {
        "@rank": "92464", 
        "arm_group": {
            "arm_group_label": "dexmedetomidine,sepsis,ED50", 
            "arm_group_type": "Other", 
            "description": "Intervention Name: dexmedetomidine dosage form: intravenous injection dosage\uff1a0.2-0.7\u03bcg/kg/h frequency: 1 duration:12 hours"
        }, 
        "brief_summary": {
            "textblock": "Septic patients in Intensive Care Unit always need mechanical ventilation and\n      conscious-sedation. But the recommended dose 0.2-0.7\u03bcg/kg/h could not run well because of\n      wide range. The purpose of this study is to find the effective dose of dexmedetomidine adult\n      septic patients of mechanical ventilation ."
        }, 
        "brief_title": "Safety Study of Dexmedetomidine in Septic Patients", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sepsis", 
            "Agitation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Psychomotor Agitation"
            ]
        }, 
        "detailed_description": {
            "textblock": "Inclusion Criteria:\n\n      Age: between 18 years mechanical ventilation RASS\u22652 A diagnosis of sepsis within 48 hours\n\n      Exclusion Criteria:\n\n      Cardiac disease Cardiac rhythm abnormalities liver dysfunction coma severe hypotension\n      muscle relaxant users\n\n      Primary Outcome Measures:\n\n      Dose of dexmedetomidine\n\n      Secondary Outcome Measures:\n\n      RASS score Requirement for rescue intervention, RASS will be recorded  per hour."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  intubated patients RASS\u22652 A diagnosis of sepsis within 48h\n\n        Exclusion Criteria:\n\n          -  Cardiac disease Cardiac rhythm abnormalities liver dysfunction coma severe\n             hypotension muscle relaxant users"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976754", 
            "org_study_id": "FirstzhejiangU"
        }, 
        "intervention": {
            "arm_group_label": "dexmedetomidine,sepsis,ED50", 
            "description": "Septic patients are randomly received 1 of 6 doses( 0.2,0.3,0.4,0.5,0.6,0.7\u03bcg/kg/h) dexmedetomidine.", 
            "intervention_name": "Dexmedetomidine", 
            "intervention_type": "Drug", 
            "other_name": "precedex"
        }, 
        "intervention_browse": {
            "mesh_term": "Dexmedetomidine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "October 30, 2013", 
        "location": {
            "contact": {
                "email": "zhangzhanqin12@sina.com", 
                "last_name": "zhanqin zhang, PHD", 
                "phone": "0086-18758191189"
            }, 
            "facility": {
                "address": {
                    "city": "Hangzhou", 
                    "country": "China", 
                    "state": "Zhejiang", 
                    "zip": "310000"
                }, 
                "name": "Zhanqin Zhang"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effective Dose of Dexmedetomidine for Moderate Sedation of Adult Intubated Septic Patients in the ICU.", 
        "overall_contact": {
            "email": "zhangzhanqin12@sina.com", 
            "last_name": "zhanqin zhang, PHD", 
            "phone": "0086-18758191189"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital of Zhejiang University", 
            "last_name": "xiangming fang, PHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Dose of dexmedetomidine", 
            "safety_issue": "Yes", 
            "time_frame": "12 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976754"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital of Zhejiang University", 
            "investigator_full_name": "zhanqin zhang", 
            "investigator_title": "PHD candidate", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "RASS score Requirement for rescue intervention, RASS will be recorded per hour.", 
            "safety_issue": "Yes", 
            "time_frame": "1 hour"
        }, 
        "source": "First Affiliated Hospital of Zhejiang University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "First Affiliated Hospital of Zhejiang University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}